Where do artificial intelligence and robotics fit into discoveries? In this session of the Newton Series, Steve Finkbeiner, MD, PhD, explains how these tools contribute to his lab’s work in understanding the fundamentals of brain cells, which he hopes will lead to discoveries in memory diseases like Alzheimer’s or Parkinson’s.

The Newton Webinar Series is inspired by the story of Isaac Newton’s extraordinary intellectual output while in quarantine during the Great London Plague of 1665, and offers an alternative to all the news related to COVID-19. Each week, we feature a conversation with Gladstone’s scientists and explore their moonshot ideas, how they approach their work, and what they think medicine may look like 10, 20, and 50 years from now.

Support Discovery Science

Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.

Donate Now

Up Next


Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

Science in Seconds featuring Steve Finkbeiner
Video October 15, 2025

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

In this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data

More News